Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
151
NCT05004571
Safety, Tolerability, and Pharmacokinetics of EQU-001 in Healthy Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 6, 2021
Completion: Sep 4, 2021
NCT05063877
Safety, Tolerability, and Exploratory Efficacy of Adjunctive EQU-001 for Seizures in Adults With Epilepsy
Phase: Phase 2
Start: Aug 31, 2021
Completion: Oct 11, 2023
NCT05473442
Study of EQU-001 for Uncontrolled Focal Onset Seizures
Start: Dec 27, 2022
Completion: Jul 1, 2023